InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: Jumpinjackas post# 1478

Thursday, 10/12/2017 6:45:12 PM

Thursday, October 12, 2017 6:45:12 PM

Post# of 2099
My take on this is that the FDA wouldn't allow them to move to phase 3 if they found evidence of data tampering. Companies can find other ways to make the data favorable (through using the inclusion/exclusion criteria) in phase 2 but that comes back to bite them in phase 3.

If twitter/internet experts can see the change in data I'm sure the FDA, with the data right in front of them, can see the change. VB-111 is a fast-track / orphan drug. Wouldn't surprise me if the FDA requested and approved the change.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News